Dr. Michael Paul Delacruz, MD

Dr. Delacruz practices at Wellspan Internal Medicine- Freedom Way in York, Pennsylvania.

Dr. Delacruz's NPI, 1629232087, was assigned on July 15, 2008. Dr. Delacruz holds Illinois license 036414355.

Dr. Delacruz's primary practice is Wellspan Internal Medicine- Freedom Way, at 2350 Freedom Way, York, PA 17402 in York County. The practice phone is (717) 851-2465.

Dr. Delacruz's primary practice is Wellspan Internal Medicine- Freedom Way in York, Pennsylvania. Dr. Delacruz is also affiliated with WellSpan York Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Delacruz to 4 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delacruz practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Delacruz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Delacruz's licenses on file in 2 states: Illinois and Pennsylvania.

CMS data shows 1,069 Medicare services from Dr. Delacruz across 14 procedure codes in 2024, for 389 Medicare patients. Medicare paid $81,772 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 389 Medicare patients who saw Dr. Delacruz in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have copd, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delacruz's median patient age at 71, with 53% women.

In 2024, Dr. Delacruz wrote 1,039 Medicare Part D claims for 179 patients. 21% of them were for generic drugs. CMS names the drug for 955 of them, across 20 drugs with 11 or more claims each, at $379,492 in total drug cost. In 2023, CMS named 525 claims across 15 drugs.

Dr. Delacruz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. Delacruz from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $276.